EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
BAXTER HLTHCARE CORP · EPINEPHRINE BITARTRATE
Open FDA's page for this record- Application number
- NDA218475
- Sponsor name
- BAXTER HLTHCARE CORP
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250228
- Review priority
- STANDARD
- Submission class code
- TYPE 5
- Submission class code description
- Type 5 - New Formulation or New Manufacturer
- Application docs
- ID
- 81393
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218475s000lbl.pdf
- Date
- 20250303
- Type
- Label
- ID
- 81429
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218475Orig1s000ltr.pdf
- Date
- 20250304
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 1
- Submission status
- TA
- Submission status date
- 20250929
- Review priority
- N/A
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Application docs
- ID
- 83642
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218475Orig1s001TAltr.pdf
- Date
- 20251003
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Active ingredients
- Name
- EPINEPHRINE BITARTRATE
- Strength
- EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)
- Product number
- 002
- Reference drug
- Yes
- Brand name
- EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- Reference standard
- Yes
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Active ingredients
- Name
- EPINEPHRINE BITARTRATE
- Strength
- EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)
